Global Fertility Services Market Estimated to Grow from $13, 655 Million in 2018 to $27, 151 Million in 2026 - ResearchAndMarkets.com

The "Fertility Services Market by Procedure and Service: Global Opportunity Analysis and Industry Forecast, 2019-2026" report has been added to ResearchAndMarkets.com's offering.

The global fertility services market generated $13,655 million in 2018 and is projected to reach $27,151 million by 2026, growing at a CAGR of 8.9% from 2019 to 2026.

Fertility services are services availed by people who are unable to conceive naturally. These services help infertile couples, single parents, and LGBT community to procreate and start a family. In vitro fertilization and other assisted reproductive technology (ART) procedures, surrogacy, and artificial insemination are some of the widely executed fertility services.

The fertility service market is anticipated to grow considerably in the near future owing to different factors such as increase in infertility rates, changes in lifestyle, and surge in incidence of male infertility cases. Low awareness with respect to fertility services in emerging markets restrict the market growth. Rise in prevalence due to increase in risk factors, such as obesity, stress, polycystic ovarian syndrome (PCOS), sexually transmitted infections, endometrial tuberculosis, and other medical conditions, is expected to offer lucrative opportunities for market growth during the forecast period.

In the procedures segment, fertility clinics accounted for around 50% of the market share of the global fertility services market in 2018. In terms of services, egg & embryo banking segment is anticipated to grow at the fastest growth rate of 11.2% during the forecast period. This segment would exhibit a prominent growth rate owing to its crucial role in preservation of embryos, which is one of the essential factors for a successful assisted reproductive technology procedure. In addition, the segment of surgical centers would exhibit prominent growth rate due to availability of various fertility procedures under one roof, development of fertility devices with advanced technologies, and the availability of a skilled workforce. By region, Asia-Pacific generated the highest revenue in the global fertility services market in 2018.

KEY BENEFITS FOR STAKEHOLDERS

• The study provides an inodepth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
• Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
• Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

Key Findings of the Fertility Services Market:

The IVF with ICSI segment accounted the highest market share of 50% in 2018 and is anticipated to grow at the fastest during the forecast period segment is anticipated to grow at the fastest rate during the forecast period.

The Asia-Pacific region was the major shareholder and accounted for the highest share of 38% in 2018.

Based on service, the egg and embryo banking segment is expected to grow at a CAGR of 11.2 % during the forecast period.

Fresh non-donor segment dominated the market share in 2018 and is anticipated to maintain its dominance during the forecast period.

In addition, Asia-Pacific is expected to experience the highest growth rate during the forecast period majorly due to surge in adoption of fertility procedures, development in the healthcare infrastructure, and rise in fertility tourism.

Key Topics Covered:

Chapter 1: Introduction

1.1. Report Description

1.2. Key Benefits For Stakeholders

1.3. Key Market Segments

1.3.1. List of Key Players Profiled In The Report

1.4. Research Methodology

1.4.1. Secondary Research

1.4.2. Primary Research

1.4.3. Analyst Tools & Models

Chapter 2: Executive Summary

2.1. Key Findings of The Study

2.2. Cxo Perspective

Chapter 3: Market Overview

3.1. Market Definition And Scope

3.2. Key Findings

3.2.1. Top Investment Pockets

3.2.2. Top Winning Strategies

3.3. Porter's Five Force Analysis

3.4. Government Regulations

3.4.1. U.S.

3.4.2. Europe

3.5. Insurance Reimbursement Scenario

3.6. Market Dynamics

3.6.1. Drivers

3.6.2. Restraints

3.6.3. Opportunity

Chapter 4: Fertility Services Market, By Procedure

4.1. Overview

4.2. Ivf With Icsi

4.3. Iui

4.4. Ivf Without Icsi

4.5. Surrogacy

4.6. Others

Chapter 5: Fertility Services Market, By Service

5.1. Overview

5.2. Fresh Non-Donor

5.3. Frozen Non-Donor

5.4. Egg & Embryo Banking

5.5. Fresh Donor

5.6. Frozen Donor

Chapter 6: Fertility Services Market, By End User

6.1. Overview

6.2. Fertility Clinics

6.3. Hospitals

6.4. Surgical Centers

6.5. Clinical Research Institutes

Chapter 7: Fertility Services Market, By Region

7.1. Overview

7.2. North America

7.3. Europe

7.4. Asia-Pacific

7.5. LAMEA

Chapter 8: Company Profiles

8.1. Apollo Hospitals Enterprise Ltd.

8.2. Care Fertility Group Ltd.

8.3. Carolinas Fertility Institute

8.4. City Fertility

8.5. Fertility Associates Limited

8.6. Genea Limited

8.7. Medicover Group (Medicover Fertility And First Egg Bank)

8.8. Monash Ivf Group Limited

8.9. Progyny Inc.

8.10. Virtus Health

For more information about this report visit https://www.researchandmarkets.com/r/fc6rj0

View source version on businesswire.com: https://www.businesswire.com/news/home/20200224005635/en/